References
- 1. Fikenzer S, Fikenzer K, Laufs U, Falz R, Schulze A, Busse M. Effects of cardioselective beta-blockade on plasma catecholamines and performance during different forms of exercise. J Sports Med Phys Fitness. 2020;60(4):643-9.10.23736/S0022-4707.19.10225-331818057
- 2. Kazuo E, Satoshi H, Kazuomi K, Effects of celiprolol and bisoprolol on blood pressure, vascular stiffness, and baroreflex sensitivity. Am J Hypertens. 2015;28(7):858-67.10.1093/ajh/hpu24525577782
- 3. Kishi T, Fujii E. Carvedilol and bisoprolol as initial therapy for adult hypertension without compelling indications. Hypertens Res. 2019;42(4):496-503.10.1038/s41440-018-0174-630948819
- 4. Leopold G. Balanced pharmacokinetics and metabolism of bisoprolol. J Cardiovasc Pharmacol. 1986;8(Suppl 11):S16-20.10.1097/00005344-198511001-000032439789
- 5. Konishi M, Haraguchi G, Kimura S, Inagaki H, Kawabata M, Hachiya H, et al. Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure. Circ J. 2010;74(6):1127-34.10.1253/circj.CJ-09-0989
- 6. Morales DR, Jackson C, Lipworth BJ, Donnan PT, Guthrie B. Adverse respiratory effect of acute β-blocker exposure in asthma: a systematic review and meta-analysis of randomized controlled trials. Chest. 2014;145(4):779-86.10.1378/chest.13-123524202435
- 7. Carazo A, Macáková K, Matoušová K, Krčmová LK, Protti M, Mladěnka P. Vitamin A update: Forms, sources, kinetics, detection, function, deficiency, therapeutic use and toxicity. Nutrients. 2021; 13(5):1703.10.3390/nu13051703815734734069881
- 8. D’Ambrosio DN, Clugston RD, Blaner WS. Vitamin A metabolism: an update. Nutrients. 2011;3(1):63-103.10.3390/nu3010063304271821350678
- 9. Chen W, Chen G. The roles of Vitamin A in the regulation of carbohydrate, lipid, and protein metabolism. J Clin Med. 2014;3(2): 453-79.10.3390/jcm3020453444969126237385
- 10. Gudas LJ, Wagner JA. Retinoids regulate stem cell differentiation. J Cell Physiol. 2011;226(2):322-30.10.1002/jcp.22417331537220836077
- 11. Stephensen CB. Vitamin A, infection, and immune function. Annu Rev Nutr. 2001;21:167-92.10.1146/annurev.nutr.21.1.16711375434
- 12. Mallipattu SK, He JC. The beneficial role of retinoids in glomerular disease. Front Med (Lausanne). 2015;2:1610.3389/fmed.2015.00016
- 13. Tilla W, Thomas B. Chapter 5.1 Handling and Restraint. In: Hans J Hedrich. The Laboratory Mouse (2nd edition). London: Academic Press; 2012:697-708.10.1016/B978-0-12-382008-2.00029-5
- 14. Zech P, Pozet N, Labeeuw M, Laville M, Hadj-Aissa A, Arkouche W, et al. Acute renal effects of beta-blockers. Am J Nephrol. 1986;6(Suppl 2): 15-9.10.1159/0001673272879466
- 15. Alsadek HB, Gamal S, Mohamed K, Walaa M. Adverse effects of bisoprolol in rats. Ady Pharmacol Clin Trials. 2019;4(3).10.23880/apct-16000164
- 16. Téllez L, Ibáñez-Samaniego L, Pérez del Villar C, Yotti R, Martínez J, Carrión L, et al. Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites. J Hepatol. 2020;73(6):1404-14.10.1016/j.jhep.2020.05.01132446716
- 17. Hall ME, Rocco MV, Morgan TM, Hamilton CA, Jordan JH, Edwards MS, et al. Beta-blocker use is associated with higher renal tissue oxygenation in hypertensive patients suspected of renal artery stenosis. Cardiorenal Med. 2016;6(4):261-8.10.1159/000445302502039527648007
- 18. Bakris GL, Hart P, Ritz E. Beta blockers in the management of chronic kidney disease. Kidney Int. 2006;70(11):1905-13.10.1038/sj.ki.500183517021610
- 19. Dumortier J, Guillaud O, Gouraud A, Pittau G, Vial T, Boillot O, et al. Atenolol hepatotoxicity: report of a complicated case. Ann Pharmacotherapy. 2009; 3(10):1719-23.10.1345/aph.1M24719776295
- 20. Rua J, Prata AR, Marques R, Silva R, Gomes B, Fraga J, et al. Carvedilol-induced liver injury, a rare cause of mixed hepatitis: A clinical case. GE Port J Gastroenterol. 2019;26(3):196-201.10.1159/000490205652807831192288
- 21. Kleiner DE. Drug-induced liver injury: The hepatic pathologist’s approach. Gastroenterol Clin North Am. 2017;46(2):273-96.10.1016/j.gtc.2017.01.004543471328506365
- 22. Mitchell NE, Harner W, Laczek J. β-Blocker-induced liver injury: A class effect with incidental rechallenge. ACG Case Rep J. 2019;6(11): e00273.10.14309/crj.0000000000000273714521332309473
- 23. Siva T, Girija S, Sankaran PK, Yuvaraj MF, Gayathri T, Lakshmi T, et al. Hepatoprotective effect of vitamin A and E on diclofenac induced hepatotoxicity in male Wistar albino rats. Int J Res Pharm Sci. 2019;10(3):1660-6.10.26452/ijrps.v10i3.1334
- 24. Fisher K, Vuppalanchi R, Saxena R. Drug-induced liver injury. Arch Pathol Lab Med. 2015;139(7):876-87.10.5858/arpa.2014-0214-RA26125428
- 25. Bashandy S, Alhazza I. The Hepatoprotective effect of β-carotene against cadmium toxicity in rats. JPT. 2008;3:457-63.10.3923/jpt.2008.457.463
- 26. Uboh FE, Ekaidem IS, Ebong PE, Umoh IB. The hepatoprotective effect of vitamin A against gasoline vapor toxicity in rats. Gastroenterology Res. 2009;2(3):162-7.10.4021/gr2009.06.1297513970827933127
- 27. Schafer F, Wang H, Kelley E, Cueno K, Buettner S. Comparing β-Carotene, vitamin E and nitric oxide as membrane. Antioxidants. 2002;383(3-4):671-81.10.1515/BC.2002.06912033456
- 28. Palace VP, Khaper N, Qin Q, Singal PK. Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radic Biol Med. 1999;26(5-6):746-61.10.1016/S0891-5849(98)00266-4
- 29. Sierra-Mondragon E, Rodríguez-Muñoz R, Namorado-Tonix C, Molina-Jijon E, Romero-Trejo D, Pedraza-Chaverri J, et al. Alltrans retinoic acid attenuates fibrotic processes by downregulating TGF-β1/Smad3 in early diabetic nephropathy. Biomolecules. 2019;9(10):525.10.3390/biom9100525684385531557800
- 30. Wagner J, Dechow C, Morath C, Lehrke I, Amann K, Waldherr R, et al. Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol. 2000;11(8):1479-87.10.1681/ASN.V118147910906161